Results from a single-center randomized controlled trial published yesterday in JAMA Internal Medicine show that azelastine, an antihistamine nasal spray used as a preventive measure, was associated with a 69% reduction of COVID-19 infection. Azelastine is a widely available over-the-counter treatment for seasonal allergies (hay fever). This clinical trial is the first to demonstrate a protective effect in a real-world …
Read More »Antihistamine nasal spray prevents COVID-19, study finds
